Impact of bronchiolitis guidelines publication on primary care prescriptions in the Italian pediatric population

Abstract In Italy, two clinical practice guidelines for the diagnosis and treatment of bronchiolitis were published in October 2014 and December 2015. We evaluated prescriptions for bronchiolitis in children aged 0–24 months before (December 2012–December 2014), in between (December 2014–December 20...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Elisa Barbieri, Anna Cantarutti, Sara Cavagnis, Luigi Cantarutti, Eugenio Baraldi, Carlo Giaquinto, Daniele Donà
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/de84865d38904a608567a9838f944f11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:de84865d38904a608567a9838f944f11
record_format dspace
spelling oai:doaj.org-article:de84865d38904a608567a9838f944f112021-12-02T13:18:07ZImpact of bronchiolitis guidelines publication on primary care prescriptions in the Italian pediatric population10.1038/s41533-021-00228-w2055-1010https://doaj.org/article/de84865d38904a608567a9838f944f112021-03-01T00:00:00Zhttps://doi.org/10.1038/s41533-021-00228-whttps://doaj.org/toc/2055-1010Abstract In Italy, two clinical practice guidelines for the diagnosis and treatment of bronchiolitis were published in October 2014 and December 2015. We evaluated prescriptions for bronchiolitis in children aged 0–24 months before (December 2012–December 2014), in between (December 2014–December 2015) and after (December 2015–December 2018) the guidelines publications. Data were retrieved from the Pedianet database; the measured outcomes were prescriptions rates of antibiotics, corticosteroids, β2-agonists, and other respiratory drugs. In 1011 out of 1581 episodes, patients received at least one treatment, with a total of 2003 prescriptions. The rate of treated bronchiolitis decreased from 66% to 57% (p < 0.001) after the publication of the second guideline; the highest reduction was in younger patients (from 57% to 44%, p = 0.013). Overall antibiotic prescriptions rate did not change, with 31.6% of the patients still receiving them. Our results confirm unnecessary non-evidence-based treatments in the primary care setting, with few changes after the guidelines publications.Elisa BarbieriAnna CantaruttiSara CavagnisLuigi CantaruttiEugenio BaraldiCarlo GiaquintoDaniele DonàNature PortfolioarticleDiseases of the respiratory systemRC705-779ENnpj Primary Care Respiratory Medicine, Vol 31, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the respiratory system
RC705-779
spellingShingle Diseases of the respiratory system
RC705-779
Elisa Barbieri
Anna Cantarutti
Sara Cavagnis
Luigi Cantarutti
Eugenio Baraldi
Carlo Giaquinto
Daniele Donà
Impact of bronchiolitis guidelines publication on primary care prescriptions in the Italian pediatric population
description Abstract In Italy, two clinical practice guidelines for the diagnosis and treatment of bronchiolitis were published in October 2014 and December 2015. We evaluated prescriptions for bronchiolitis in children aged 0–24 months before (December 2012–December 2014), in between (December 2014–December 2015) and after (December 2015–December 2018) the guidelines publications. Data were retrieved from the Pedianet database; the measured outcomes were prescriptions rates of antibiotics, corticosteroids, β2-agonists, and other respiratory drugs. In 1011 out of 1581 episodes, patients received at least one treatment, with a total of 2003 prescriptions. The rate of treated bronchiolitis decreased from 66% to 57% (p < 0.001) after the publication of the second guideline; the highest reduction was in younger patients (from 57% to 44%, p = 0.013). Overall antibiotic prescriptions rate did not change, with 31.6% of the patients still receiving them. Our results confirm unnecessary non-evidence-based treatments in the primary care setting, with few changes after the guidelines publications.
format article
author Elisa Barbieri
Anna Cantarutti
Sara Cavagnis
Luigi Cantarutti
Eugenio Baraldi
Carlo Giaquinto
Daniele Donà
author_facet Elisa Barbieri
Anna Cantarutti
Sara Cavagnis
Luigi Cantarutti
Eugenio Baraldi
Carlo Giaquinto
Daniele Donà
author_sort Elisa Barbieri
title Impact of bronchiolitis guidelines publication on primary care prescriptions in the Italian pediatric population
title_short Impact of bronchiolitis guidelines publication on primary care prescriptions in the Italian pediatric population
title_full Impact of bronchiolitis guidelines publication on primary care prescriptions in the Italian pediatric population
title_fullStr Impact of bronchiolitis guidelines publication on primary care prescriptions in the Italian pediatric population
title_full_unstemmed Impact of bronchiolitis guidelines publication on primary care prescriptions in the Italian pediatric population
title_sort impact of bronchiolitis guidelines publication on primary care prescriptions in the italian pediatric population
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/de84865d38904a608567a9838f944f11
work_keys_str_mv AT elisabarbieri impactofbronchiolitisguidelinespublicationonprimarycareprescriptionsintheitalianpediatricpopulation
AT annacantarutti impactofbronchiolitisguidelinespublicationonprimarycareprescriptionsintheitalianpediatricpopulation
AT saracavagnis impactofbronchiolitisguidelinespublicationonprimarycareprescriptionsintheitalianpediatricpopulation
AT luigicantarutti impactofbronchiolitisguidelinespublicationonprimarycareprescriptionsintheitalianpediatricpopulation
AT eugeniobaraldi impactofbronchiolitisguidelinespublicationonprimarycareprescriptionsintheitalianpediatricpopulation
AT carlogiaquinto impactofbronchiolitisguidelinespublicationonprimarycareprescriptionsintheitalianpediatricpopulation
AT danieledona impactofbronchiolitisguidelinespublicationonprimarycareprescriptionsintheitalianpediatricpopulation
_version_ 1718393301001830400